Skip to content

The identification of cervical intraepithelial neoplasia and invasive cancer using artificial intelligence based on electronic cytological image : a case-control study.

The cervical cancer screening program

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034131
Enrollment
Unknown
Registered
2020-06-25
Start date
2017-03-01
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical intraepithelial neoplasia and invasive cancer

Interventions

techonology&#32
based&#32
on&#32
deep&#32
learning liquid-based&#32
cytology Cobas&#32
Gold Standard:A standard colposcopy with directed four-quadrant biopsy at the squamo-columnar junction and endocervical curettage
test
Index test:Artificial&#32
intelligence&#32
cytology&#32

Sponsors

National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 64 Years

Inclusion criteria

Inclusion criteria: (1) Women aged 20-64 years; (2) Having intact cervis and no history of CIN; (3) Having self-reported genital symptoms in cervix, or suspected cervical invasive cancer in pelvic examination, including unexplained lower genital tract bleeding or contact bleeding, visible cervix ucler, tumor or neoplasm, or suspicious cancer; (4) Had any abnormality in previous screen, including abnormality in cytology, visual inspection with acetic acid or Lugols Iodine, or HPV positivity at least two months ago; (5) Receive colposcopy-directed biopsy for final diagnosis.

Exclusion criteria

Exclusion criteria: (1) women who were pregnant or in suckling period; (2) women who ever had history of cervical cancer or precancerous lesions; (3) women wo had mental diseases or cognitive disorder, or other health conditions that not enable to the participation.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;accuracy;positive predictive value;negative predictive value;

Secondary

MeasureTime frame
positive likelihood ratio;negative likelihood ratio;odds ratio;

Countries

China

Contacts

Public ContactLinhong Wang

National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention

linhong@chinawch.org.cn+86 13311088556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026